Active: new fund Jan 2025 Verified 4 Nov 2026
Genesis BioCapital
Invests in and creates companies in medicine.
- Type
- VC firm
- Location
- Chattanooga, Tennessee, United States
- Stages
- Pre-seed
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- $18.5M Genesis BioCapital Fund I (Form D amount sold, 2025)
- Latest fund or filing
- 23 Jan 2026
- Website
- genesisbiocapital.com
Fund filings (SEC Form D)
- Latest fund on file
- Genesis BioCapital Fund I
- Filed
- 23 Jan 2026 (amendment)
- Fund size
- $18M (amount sold)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Genesis BioCapital, the paid file holds: 1 named decision-maker with roles; firm contact email (domain checked); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 14 lists
Venture capital firms in Tennessee (33)Pre-seed biotech investors in the US (81)Pre-seed biotech investors (148)Pre-seed healthtech investors in the US (225)Emerging VC managers in the US (274)Biotech venture capital firms in the US (297)Pre-seed healthtech investors (408)Biotech investors (484)Pre-seed investors in the US (549)Healthtech venture capital firms in the US (709)Pre-seed investors (988)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)